Core Veterinary Medicine Terms and Definitions
Veterinary medicine terms describe drugs, procedures, and regulatory classifications used in animal healthcare. Common terms include pharmacokinetics, which measures how a drug is absorbed, distributed, metabolized, and excreted, and pharmacodynamics, which studies the drug's biochemical and physiological effects. The global veterinary pharmaceuticals market was valued at approximately 34 billion USD in 2023, with parasiticides and vaccines representing the largest segments according to industry analysis.
Key terms in veterinary pharmacology include the minimum inhibitory concentration, the lowest concentration of an antimicrobial that prevents visible growth of a microorganism, and the withdrawal period, the required time between the last treatment and when the animal or its products can enter the food supply. The FDA Center for Veterinary Medicine oversees the approval of new animal drugs, and in 2023, the agency approved multiple new generic animal drugs to expand access and reduce costs per the FDA's guidance documents.
Regulatory Frameworks and Compliance Terms
Animal Drug Approval Process
The New Animal Drug Application is the formal submission to the FDA demonstrating a drug is safe and effective for its intended use. The FDA's Center for Veterinary Medicine evaluates data on animal safety, human food safety from edible animal products, and manufacturing quality. In 2024, the FDA updated guidance to streamline the review process for certain generic animal drugs, aiming to shorten approval timelines and address drug shortages as detailed on the FDA website.
Key Compliance Concepts
Veterinary medicine terms related to compliance include extralabel drug use, which refers to using an approved animal or human drug in a manner not in accordance with the approved labeling, and is regulated under the Animal Medicinal Drug Use Clarification Act. Good Manufacturing Practice standards ensure products are consistently produced and controlled according to quality standards, and the FDA conducts inspections of veterinary drug manufacturing facilities to enforce these standards per SEC filings from major animal health companies.
Industry Structure and Market Leaders
The veterinary medicine industry is dominated by a small number of large multinational corporations, with the top five companies controlling over half of the global market share. Zoetis, a spinoff from Pfizer, is the world's largest animal health company by revenue, followed by Elanco Animal Health, a subsidiary of Eli Lilly, and Merck Animal Health based on market reports.
Veterinary medicine terms also encompass biologics, which include vaccines, immunoglobulins, and diagnostics derived from biological sources. The global animal vaccines market is projected to grow steadily, driven by increasing pet ownership, rising demand for animal protein, and the emergence of zoonotic diseases. Companies are investing in recombinant vaccine technology and digital health tools to improve disease prevention and treatment outcomes in both companion and food-producing animals with data from industry analysis.